IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation services, congratulates Nexus Pharmaceuticals LLC for receiving a Facility of the Year Award (FOYA) from The International Society for Pharmaceutical Engineering (ISPE). IPS is proud to have been a partner in the success of the “Project Tomorrow” sterile injectables facility in Pleasant Prairie, Wisconsin. The IPS team of experts provided a range of services for the project, including architecture, engineering, process design, and construction management support.
“This recognition is a testament to our dedication to bring state-of-the-art pharmaceutical manufacturing back to the United States and we are honored to be recognized by this award.”
The ISPE FOYA program recognizes state-of-the-art pharmaceutical manufacturing facilities utilizing innovative design and construction strategies to produce high-quality, safe, cost-effective medicines. The FOYA judges found the design and technology included in Project Tomorrow “impressive and in line with current industry standards. However, delivering these capabilities as a small generic company, with a keen eye on continued expansion, showcases their mission in action and really makes this project special.”
The facility was a dream that started in the living room of Mariam S. Darsot, Nexus Co-Founder and Chair of the Board of Directors. Mariam sought to efficiently and cost-effectively produce safe, injectable drugs for Americans who are facing critically short drug supply. From her living room to reality, the design allows for physically expanding operations in stages for the next ten years.
“We are eternally grateful to our wonderful team and our partners at IPS that made this possible,” stated Usman Ahmed, Chief Executive Officer and President at Nexus Pharmaceuticals. “This recognition is a testament to our dedication to bring state-of-the-art pharmaceutical manufacturing back to the United States and we are honored to be recognized by this award.”
IPS designed Project Tomorrow using design concepts that provide additional efficiency that has not been seen before in pharmaceutical manufacturing. This multiuse facility is a major milestone for supplementing Nexus’ aseptic fill/finish capacity. It features both the application of state-of-the-art process technologies as well as an aesthetically-focused facility concept. It is designed as an innovative, flexible, easily expandable, efficient, and forward-looking facility to reduce drug shortages in the US.